They beat by seven points on revenue, raised the low end of the guide, and refused to move the EPS number by a penny.
Thesis: Pricing power is real and verifiable: 50bps positive price held with volume growth, gross margin expanded on price and logistics relief, PIC returned to growth once Tyvek supply loosened. But the headline beat is a calendar artifact. Ex-five shipping days the number is just over 7% against a 6% midpoint, Q4 reverses that, and management conceded tougher comps in the back half. The real tell is the guidance: revenue low end up, adjusted EPS reiterated at $13.00 to $13.60 while Q1 operating margin already runs ahead of the full-year guide, and GAAP cut to $8.14 to $8.74 on an unquantified tax item. Reiterating EPS on a raised revenue line means the back half absorbs costs management won't size. The 2024 margin math, MSA exiting for 100bps and Titan turning accretive, is the actual bull case, and it's not in the numbers yet.
Verdict: HOLD — Conviction: MEDIUM
Catalyst: Q2 reporting ex-days growth holding above 6% with operating margin still ahead of the full-year guide, plus confirmation that the MSA exit lands the 100bps gross margin pickup and Titan hits $30 to $35M on schedule.
Key Risk: Second-half normalization. Five fewer days in Q4, tougher comps, and an EPS guide held flat against a raised revenue line with costs management declines to quantify. UroLift patient flow still down 3.7% through February.
The Tell: CFO on the direct question of why margin guidance wasn't raised when Q1 operating margin came in at 25.8% against a full-year guide: "I think one thing I would just like to point out is it's May. It's very early in the year." One sentence, no numbers, question closed. Directly after beat-and-raise on revenue with EPS held flat, the refusal to size the margin cadence says the back half carries costs.
Friction Level: MODERATE_FRICTION — Both sides agree Q1 was calendar-flattered by five shipping days and that pricing is real at 50bps. Disagreement is whether the raised revenue low end plus Q1 operating margin of 25.8% running ahead of full-year guidance means Street estimates are too low, or that a reiterated adjusted EPS of $13.00 to $13.60 means management is hiding back-half costs they won't quantify.
Report not found
The report data is no longer available. Please return to the archive.